Galapagos.
biotechnology company based in Leiden, Netherlands
- Reports this week
- 0
- Active events
- 0
- Connections
- 28
What's happening
Gone quiet
No new reports in 90+ days-
The company Galapagos began using LinkedIn as a platform for information sharing.Some support2 reports
-
Aaron Cox joined Galapagos as CFO, and Dan joined the company's senior team.Some support2 reports
-
Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.Some support1 report
-
Jane Griffiths and Dawn Svoronos were appointed to the board of directors of Galapagos on July 24, 2025.Some support1 report
-
Galapagos NV is based in Mechelen, Belgium, and Gilead Therapeutics holds subscription rights for Galapagos shares.Some support3 reports
-
Galapagos and Takeda entered a collaboration and licensing agreement for TYK2 inhibitor development.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Galapagos this week
News at the entities that move Galapagos most-
Gilead Sciences StructuralRequired regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Moves Galapagos
-
Hormuz OperationalThe government has ended the excise duty discount on fuel, while negotiations are underway to unblock the Strait of Hormuz.Moves Galapagos
-
LinkedIn Mentioned togetherBoth LinkedIn and Google are currently being utilized as platforms for news distribution.Moves Galapagos
-
Europe Shared contextThe European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Moves Galapagos
-
Netherlands Shared contextAruba, Curaçao, Sint Maarten, and the Netherlands collaborated on digitizing historical meteorological archives.Moves Galapagos
-
Belgium Shared contextA research center is addressing various industry challenges specific to the Roeselare area.Moves Galapagos
Connections
The 8 strongest of 28, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Gilead Structural
Gilead holds subscription rights for Galapagos shares and the two entities maintain a partnership.
-
Gilead Sciences Structural
Galapagos and Gilead Sciences maintain a structural relationship defined by a transformational agreement and board representation.
-
Paul Stoffels Structural
Paul Stoffels served as the CEO and Chair of the Board for Galapagos.
-
LinkedIn Mentioned together
Galapagos utilizes LinkedIn as a professional networking platform for company updates and information dissemination.
-
Hormuz Operational
The company utilizes the Hormuz Strait as a transit point for its maritime operations, which are currently underway despite ongoing strikes.
-
Belgium Shared context
Galapagos conducts operations and is based in Belgium, using the country as a positional backdrop for its business activities.
-
Europe Shared context
Galapagos operates within the context of Europe's biotech industry.
-
Netherlands Shared context
Galapagos is a biotechnology company based in the Netherlands.
History
Events by the month they beganJune 2026
6 events- The company Galapagos began using LinkedIn as a platform for information sharing.
- Aaron Cox joined Galapagos as CFO, and Dan joined the company's senior team.
- Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.
- Jane Griffiths and Dawn Svoronos were appointed to the board of directors of Galapagos on July 24, 2025.
- Galapagos NV is based in Mechelen, Belgium, and Gilead Therapeutics holds subscription rights for Galapagos shares.
- Galapagos and Takeda entered a collaboration and licensing agreement for TYK2 inhibitor development.